drugset / Trial / NCT00133796
Neoadjuvant Herceptin in Patients With Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purposes of this study are to better understand how Herceptin causes tumors to become smaller and to find out how effective Herceptin, together with chemotherapy, is in treating advanced breast cancer.
Timeline
- Start
- 2001-10
- Primary completion
- 2005-09
- Completion
- 2007-04
Outcome
Outcome not reported
Stopped (Enrollment): “Closed to accrual 4/19/2006 / Study doesn't qualify for reporting.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trastuzumab | Monoclonal antibody | — | — |